GHPC represents a unique intersection of business, scientific and humanitarian impact. Though its immediate and long range goals are focused on novel, versatile and flexible nutritional delivery technologies directed to the energy/endurance markets and the reduction of atherosclerotic plaque (as well as the regression of atherosclerotic lesions), GHPC will focus on patients coping with other chronic diseases such as HIV/AIDS worldwide where nutritional demands are paramount. With GHPC's leadership background, the product portfolio can obtain remarkable market penetration in the developed and developing world.

 
Big Pharma sometimes perpetuates conditions wherein its drugs often cause major metabolic problems and toxic side effects.  GHPC will advance nutritionally-based and non-toxic interventions, often capable of practically managing disease states without dangerous drugs - as well as in the important and increasingly emphasized area of preventative medicine. At the same time, GHPC will labor to provide supplements to other modern drug interventions so as to mitigate or ameliorate side effects and metabolic stresses and perhaps to augment or enhance the effectiveness of the pharmacological treatments; thus, providing profitable solutions within wider treatment contexts. GHPC is also actively engaged in pursuing and acquiring additional compounds and biotechnologies that satisfy and advance this philosophy.

Because of toxicities and metabolic stresses associated with HIV treatment, international funding mechanisms developed over the last decade for the treatment of chronic disease in Africa actively seek the solutions GHPC's approach will provide.  GHPC already has scientifically validated, patented and proven products that will sell exponentially in global markets. Each new and improved product will be systematically validated. Cultivated relationships are in place to move quickly into an underserved market via the auspices of UNAIDS, The Global Fund, PEPFAR, Heads of Government, NATO and military markets worldwide, Global professional, College and Olympic athletic markets, geriatric communities, hospitals and clinics, medical professionals, National and local Health authorities worldwide.  We have a detailed, strategic plan to access thousands of vertical sales and supply chains throughout Medical, Nutritional, Pharma and Nutraceutical markets. Though emphasizing scientific and verifiable proof of efficacy wherever needed, Global Health Partners Corp is not focused on humanitarian fronts alone.  Both in-house and academic research shows significant market potential for GHPC's product portfolio in traditional consumer and clinical markets. 
 
The products, the vision, and an experienced and committed team are all in place. With a scientifically elegant approach, GHPC maintains genuine and real possibilities to combine strong business acumen with the science and art of alleviating disease and suffering.  According to its mission, GHPC will mark its success by fighting disease uniquely; through creating health.